The physiological function of drug-transporting P-glycoproteins
- PMID: 9441946
- DOI: 10.1006/scbi.1997.0068
The physiological function of drug-transporting P-glycoproteins
Abstract
The mammalian drug-transporting or mdr1-type P-glycoproteins can extrude a range of structurally diverse, toxic xenobiotic compounds from cells. Our analysis of knockout mice lacking one or both of the mdr1-type P-glycoproteins indicates that a major function of these proteins is the protection of organisms against many of the toxic xenobiotics to which they can potentially be exposed in nature. P-glycoprotein confers protection by limiting the uptake of compounds from the gastrointestinal tract, and by stimulating excretion of compounds in the liver, kidney, and intestine. Moreover, P-glycoprotein in the blood-brain barrier and other blood-tissue barriers protects sensitive organs from exposure to toxic compounds that may have entered the bloodstream. Although we cannot exclude additional physiological functions for mdr1-type P-glycoproteins, these are not vital, since the mdr1-deficient mice are viable and fertile, and do not display obvious phenotypic abnormalities other than hypersensitivity to drugs.
Similar articles
-
Pharmacological insights from P-glycoprotein knockout mice.Int J Clin Pharmacol Ther. 1998 Jan;36(1):9-13. Int J Clin Pharmacol Ther. 1998. PMID: 9476142 Review.
-
Recent progress in P-glycoprotein research.Anticancer Drug Des. 1999 Apr;14(2):115-21. Anticancer Drug Des. 1999. PMID: 10405638 Review.
-
Importance of P-glycoprotein at blood-tissue barriers.Trends Pharmacol Sci. 2004 Aug;25(8):423-9. doi: 10.1016/j.tips.2004.06.002. Trends Pharmacol Sci. 2004. PMID: 15276711 Review.
-
Does inhibition of P-glycoprotein lead to drug-drug interactions?Toxicol Lett. 2005 Apr 28;156(3):319-29. doi: 10.1016/j.toxlet.2004.12.008. Epub 2005 Jan 18. Toxicol Lett. 2005. PMID: 15763631 Review.
-
Pluronic P85 enhances the delivery of digoxin to the brain: in vitro and in vivo studies.J Pharmacol Exp Ther. 2001 Feb;296(2):551-7. J Pharmacol Exp Ther. 2001. PMID: 11160643
Cited by
-
Non-Nutritive Sweeteners Acesulfame Potassium and Sucralose Are Competitive Inhibitors of the Human P-glycoprotein/Multidrug Resistance Protein 1 (PGP/MDR1).Nutrients. 2023 Feb 23;15(5):1118. doi: 10.3390/nu15051118. Nutrients. 2023. PMID: 36904118 Free PMC article.
-
In silico analysis of the binding of anthelmintics to Caenorhabditis elegansP-glycoprotein 1.Int J Parasitol Drugs Drug Resist. 2016 Dec;6(3):299-313. doi: 10.1016/j.ijpddr.2016.09.001. Epub 2016 Sep 15. Int J Parasitol Drugs Drug Resist. 2016. PMID: 27746191 Free PMC article.
-
Brain endothelial cells as pharmacological targets in brain tumors.Mol Neurobiol. 2004 Oct;30(2):157-83. doi: 10.1385/MN:30:2:157. Mol Neurobiol. 2004. PMID: 15475625 Review.
-
Effect of hemorrhagic shock on apoptosis and energy-dependent efflux system in the brain.Neurochem Res. 2002 Dec;27(12):1625-32. doi: 10.1023/a:1021630926302. Neurochem Res. 2002. PMID: 12515315
-
Effect of ABCB1 C3435T polymorphism on docetaxel pharmacokinetics according to menopausal status in breast cancer patients.Br J Cancer. 2010 Aug 10;103(4):560-6. doi: 10.1038/sj.bjc.6605789. Epub 2010 Jul 13. Br J Cancer. 2010. PMID: 20628376 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources